Home >
FEATURED COMMENTARY
Feb 11, 2016 12:28 PM
The American Board of Internal Medicine (ABIM) invited all ABIM-certified physicians to participate in a review of the blueprints that outline content areas for subspecialty Maintenance of...
Feb 11, 2016 11:19 AM
Most times, I feel excited to be an oncologist. Oncology research is accelerating and every week brings more news, whether it be a deeper understanding of tumor genomics, a broader understanding of...
Feb 08, 2016 3:32 PM
During 2 weeks of challenging inpatient hospital service, I made it my goal to give my residents the best possible exposure to our field, and to allow them as much autonomy as possible.
Feb 03, 2016 5:00 PM
ASCO CEO Dr. Allen S. Lichter reflects on an optimistic approach to the challenges of providing high-quality cancer care around the globe on World Cancer Day.
Feb 03, 2016 4:55 PM
The decision to scale up the provision of oral chemotherapy was a watershed event in the regulation of private health insurance in Brazil; however, prospects for expanded access to such medicines in...
Jan 19, 2016 7:43 PM
I had the opportunity to interview Dr. Cardinale Smith about Oncotalk, a communications course that she coordinates for oncology professionals and trainees.
Jan 19, 2016 2:57 PM
There is plenty of research that proves what we intuitively know: a person who is well informed and invested in her treatment is more likely to seek out the resources she needs to cope with the...
Jan 11, 2016 2:26 PM
This is a story of how small things really can make a big difference: a nurse anticipating a problem for a patient, a biomedical engineer open to collaboration, and a care provider taking an...

Latest Comments & Discussions


Michael A. Thompson, MD, PhD
Feb 10, 2016 2:32 PM
NCI update: NCI MATCH: A Status Report & Future Directions [2/1/16] - by Barbara Conley, MD http://ow.ly/XROdG  

Anis Toumeh, MD
Feb 10, 2016 11:58 AM
1- Clinically, this is more likely to be a distant recurrence of her disease (within 2-3 years of diagnosis). As per ASCO guidelines (Van...

ASCO University
Feb 10, 2016 9:53 AM
Discussion Questions Choice for site of biopsy? LN vs. Bone and merits/pros/cons for tissue for molecular profiling vs. confirmation...

ASCO University
Feb 10, 2016 9:52 AM
Patient Case Your 58 year old patient with a previous history of Stage 1 triple negative breast cancer (TNBC) presents to you for...

ASCO University
Feb 10, 2016 9:49 AM

Read more to answer the following questions: 1) Choice for site of biopsy? LN vs. Bone and merits/pros/cons for tissue for molecular...

Pages

Most Read

ASCO CEO Dr. Allen S. Lichter reflects on an optimistic approach to the challenges of providing high-quality cancer care around the globe on World Cancer Day.
I find I greet the new year with both anticipation and anxiety; this year, however, has thus far been tinged with sadness.
ASCO is seeking candidates for Editor in Chief of ASCO Connection. The 5-year term will begin in December 2016; please apply by March 1, 2016.
60.4% of women diagnosed with stage 0-IV breast cancer within the last 5 year were willing to accept an antidepressant from an oncologist and only 26.3% preferred treatment from a mental health professional.
Read more to answer the following questions: 1) Choice for site of biopsy? LN vs. Bone and merits/pros/cons for tissue for molecular profiling vs. confirmation of distant recurrence? 2) Would you recommend clinical genetics consultation for BRCA testing?  Expanded panel testing? 3) What additional...

Tweets from ASCO

Tweets from Oncology Community